These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 26130119

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension.
    Tsujimoto T, Kajio H.
    J Am Heart Assoc; 2020 Dec; 9(23):e018827. PubMed ID: 33222584
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction.
    Wei FF, Zhou Y, Wu Y, Chen X, He J, Dong Y, Staessen JA, Liu C.
    Hypertens Res; 2023 Feb; 46(2):475-484. PubMed ID: 36380201
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
    Tsujimoto T, Kajio H.
    Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
    [Abstract] [Full Text] [Related]

  • 52. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial.
    Sandesara PB, O'Neal WT, Kelli HM, Topel M, Samman-Tahhan A, Sperling LS.
    J Am Heart Assoc; 2018 Feb 23; 7(5):. PubMed ID: 29475874
    [Abstract] [Full Text] [Related]

  • 53. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    Kosmala W, Rojek A, Przewlocka-Kosmala M, Wright L, Mysiak A, Marwick TH.
    J Am Coll Cardiol; 2016 Oct 25; 68(17):1823-1834. PubMed ID: 27765184
    [Abstract] [Full Text] [Related]

  • 54. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
    Silverman DN, Plante TB, Infeld M, Callas PW, Juraschek SP, Dougherty GB, Meyer M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1916598. PubMed ID: 31800067
    [Abstract] [Full Text] [Related]

  • 55. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB, Hammadah M, Samman-Tahhan A, Kelli HM, O'Neal WT.
    Clin Cardiol; 2017 Sep 02; 40(9):692-696. PubMed ID: 28444995
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
    Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Solomon SD, McMurray JJV.
    Lancet; 2024 Sep 21; 404(10458):1119-1131. PubMed ID: 39232490
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.